# RE and Probiotics in MAFLD/NAFLD

> **NCT06563921** · NA · NOT_YET_RECRUITING · sponsor: **Nicolaus Copernicus University** · enrollment: 180 (estimated)

## Conditions studied

- NASH
- NAFLD
- MAFLD

## Interventions

- **BEHAVIORAL:** physical exercise programme
- **DIETARY_SUPPLEMENT:** probiotics supplementation
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06563921
- **Lead sponsor:** Nicolaus Copernicus University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2031-04-10
- **Final completion:** 2036-04-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06563921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06563921, "RE and Probiotics in MAFLD/NAFLD". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06563921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*